Curi RMB Capital LLC lessened its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 38.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 50,890 shares of the financial services provider's stock after selling 31,141 shares during the quarter. Curi RMB Capital LLC's holdings in CME Group were worth $13,501,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Heartland Bank & Trust Co purchased a new position in shares of CME Group during the 1st quarter valued at $377,000. Catalyst Capital Advisors LLC raised its stake in CME Group by 256.9% in the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after acquiring an additional 2,636 shares during the period. OMNI 360 Wealth Inc. purchased a new stake in CME Group during the first quarter valued at about $367,000. Fulcrum Equity Management bought a new position in CME Group during the first quarter worth about $258,000. Finally, AIA Group Ltd increased its stake in shares of CME Group by 17.8% in the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock worth $4,416,000 after purchasing an additional 2,510 shares in the last quarter. 87.75% of the stock is owned by institutional investors.
Insider Buying and Selling at CME Group
In related news, insider Sunil Cutinho sold 11,896 shares of the firm's stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Charles P. Carey sold 500 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the completion of the sale, the director owned 4,900 shares of the company's stock, valued at $1,300,215. The trade was a 9.26% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.30% of the company's stock.
Wall Street Analyst Weigh In
CME has been the subject of several analyst reports. Erste Group Bank downgraded shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Oppenheimer raised their price target on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Barclays set a $298.00 target price on CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. Finally, Piper Sandler upped their price target on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research report on Tuesday, July 15th. Four analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $260.60.
Get Our Latest Research Report on CME
CME Group Price Performance
Shares of NASDAQ CME traded up $0.64 during midday trading on Monday, hitting $262.58. 1,973,519 shares of the company's stock were exchanged, compared to its average volume of 2,309,686. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The business's fifty day moving average price is $274.96 and its two-hundred day moving average price is $270.15. The company has a market cap of $94.63 billion, a price-to-earnings ratio of 25.42, a PEG ratio of 4.74 and a beta of 0.43. CME Group Inc. has a 12-month low of $212.38 and a 12-month high of $290.79.
CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the business posted $2.56 earnings per share. CME Group's revenue for the quarter was up 10.4% on a year-over-year basis. As a group, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio is currently 48.40%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.